Nephrology2019-08-27T17:00:35+00:00

Nephrology Trials

Accelerating Nephrology Trials Globally

Within the past five years, nearly 30% of initiated or ongoing studies at Biorasi were those involving CKD subject populations. Biorasi has the experience to deliver Clinical Research Optimized™ in Nephrology clinical trials.

OVERCOMING COMPLEX TRIAL CHALLENGES

Biorasi delivers faster, higher quality trials in challenging renal indications by combining an industry-leading patient engagement program and a best-in-class data sciences department, all backed by a full-service global CRO for exceptional nephrology trial delivery.
Biorasi is an award-winning CRO accelerating nephrology clinical development for companies around the world.

Accelerating Nephrology Trials Globally

Biorasi delivers faster, higher quality trials in challenging renal indications by combining an industry-leading patient engagement program and a best-in-class data sciences department, all backed by a full-service global CRO for exceptional nephrology trial delivery. Biorasi provides sponsors with:

Nephrology Capabilities

Deep Understanding of Nephrology and the CKD Population

Biorasi has a long history of running successful trials in the chronic kidney disease space, and we’ve used that time to become true experts in nephrology clinical research. We’ve forged partnerships and connections with some of the top independent sites and site/LDO networks both within the United States, and abroad. We’ve built deep and lasting relationships with respected investigators. Our staff has trained extensively on managing and monitoring these uniquely challenging trials. In short, we are well set up to deliver Clinical Research Optimized™ in your nephrology trial.

Let us be part of your important work to find a solution to design your trial.

Contact Us Today

Related Resources

Acute Kidney Injury (AKI): Management and Outcome

By |Categories: Blog Articles|Tags: , , , |

In my previous article, I explained the types, causes and symptoms of Acute Kidney Injury (AKI). Here, I’ll share how physicians treat and manage AKI, as well as what to expect. CRRT or intermittent hemodialysis? To treat AKI, nephrologists primarily use renal replacement therapy (RRT), which includes intermittent hemodialysis, peritoneal hemodialysis, various forms of CRRT, and “hybrid” therapies such as prolonged intermittent renal replacement therapy (PIRRT) or sustained low-efficiency hemodialysis (SLED). A few clinical trials are taking a look at CRRT and intermittent hemodialysis under different conditions.

Acute Kidney Injury (AKI): Why aggressive treatment early is a must

By |Categories: Blog Articles|Tags: , |

What is AKI? AKI is a sudden, reversible decline in the kidney’s glomerular filtration rate (GFR); in other words, its ability to filter metabolic waste. This kidney damage causes an elevation of serum urea and creatinine, which affects the body's ability to function properly. Most AKI cases are reversible. However, it's important to treat AKI as early as possible to avoid its progression to chronic kidney disease or kidney failure.

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist
close-link

Schedule a call with one of our experts today

Let us know how we can help. Complete the form below and we will schedule a call
close-link

Start your FREE Trial Rescue Assessment!

Complete the form below and we will provide our free trial rescue assessment.
close-link

Download our Patient-Centric Trials White Paper

Complete the form below to receive a link to download this white paper
close-link

Download our Data Science White Paper

Complete the form below to receive a link to download this white paper
close-link

Schedule a TALOS™ Control Center Demo

Complete the form below to schedule a demo with our program development team
close-link

Download our Rare Disease Checklist

Complete the form below to receive a link to download this checklist
close-link

Download our Dermatology White Paper

Complete the form below to receive a link to download this white paper
close-link

Get Access to "Making Most of Trial Data" Webinar

Complete the form below to receive a link to access this webinar
close-link

Download our Precision Oncology White Paper

Complete the form below to receive a link to download this whitepaper
close-link

Download our Rare Disease White Paper

Complete the form below to receive a link to download this whitepaper
close-link

Get access to "Strategies for Successful Digital Therapeutics Clinical Trials" Webinar

Complete the form below to receive a link to access this on-demand webinar
close-link